United Kingdom· GB-APID-13465911000001107
Zemplar 4microgram capsules
A paricalcitol product containing paricalcitol, registered in United Kingdom by AbbVie Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Paricalcitol is registered in 12 of 19 countries.
Countries holding a registration under ATC H05BX02 (paricalcitol), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Paricalcitol · ATC H05BX02
12 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paricalcitol costs, country by country.
Normalised to the WHO defined daily dose (2 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Paricalcitol · price per daily dose (2 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$11.31
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Paricalcitol
- Manufacturer
- AbbVie Ltd
- Country
- United Kingdom (GB)
- ATC code
- H05BX02
- ATC class
- Paricalcitol
- Defined daily dose
- 2 mcg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5013158776708
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
285 interactions on record for paricalcitol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paricalcitol · interactions on record
285 records
- 11 severe
- 108 moderate
- 166 info
Most severe, free to view
- SucralfateA02BX02severe
- ErgocalciferolA11CC01severe
- DihydrotachysterolA11CC02severe
- CalcitriolA11CC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Paricalcitol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesParicalcitolBionpharma Inc.
- CzechiaPARICALCITOL ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- SpainPARICALCITOL ACCORD 1 MICROGRAMO CAPSULAS BLANDAS EFGAccord Healthcare S.L.U.
- FinlandParicalcitol AccordAccord Healthcare B.V.
- GermanyParicalcitol AccordAccord Healthcare B.V.
- NetherlandsParicalcitol Accord 2 microgram/ml oplossing voor injectieAccord Healthcare B.V.
- SwitzerlandZemplar 1 µg, WeichkapselnAbbVie AG
- NorwayParicalcitol AlternovaAlternova A/S
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Paricalcitol Accord, Zemplar
- Bulgaria · Тевапаривит
- Cyprus · Rextol
- Czechia · Paricalcitol Accord, Paricalcitol Agmed
- Germany · Paricalcitol Accord, Paricalcitol Hexal
- Denmark · Paricalcitol Pharmathen
- Spain · Paricalcitol Accord, Paricalcitol Accordpharma
- Finland · Paricalcitol Accord, Paricalcitol Alternova
- Greece · Aricitol, Panozin
- Croatia · Parkol, Zemplar
- Hungary · Paricalcitol Fresenius, Paricalcitol Onkogen
- Ireland · Paricalcitol Pinewood Laboratories, Zemplar
- Italy · Paracalcitolo Mylan, Paracalcitolo Sandoz
- Luxembourg · Porontazin
- Netherlands · Paricalcitol Accord, Paricalcitol Heaton
- Norway · Paricalcitol Alternova
- Poland · Paricalcitol Fresenius
- Portugal · Paricalcitol Accord, Paricalcitol Altan
- Romania · Paricalcitol, Rextol
- Sweden · Paricalcitol Accord, Paricalcitol Alternova
- Slovenia · Zemplar
- Slovakia · Paricalcitol Heaton, Zemplar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/38bcdcad-14ef-4e16-9e7d-950d0f853b1a GET /v1/drugs/38bcdcad-14ef-4e16-9e7d-950d0f853b1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "13465911000001107",
"desc": "Zemplar 4microgram capsules (AbbVie Ltd)",
"form": "Oral capsule",
"vpid": "41767611000001108",
"source": "dmd",
"vtm_id": "777082005",
"strength": "4 microgram",
"substance": "Paricalcitol",
"ingredient": "Paricalcitol",
"supplier_code": "20741511000001103"
}See everything about paricalcitol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.